News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Affibody to Start Clinical Development of a New Approach for the Diagnosis of Cancer
September 28, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
STOCKHOLM, Sweden, September 26, 2007. Swedish MPA gives go ahead for the clinical trial of Affibody’s molecular imaging agent designed to improve the diagnosis of HER2-positive breast cancer.
Twitter
LinkedIn
Facebook
Email
Print
Europe
MORE ON THIS TOPIC
Manufacturing
Samsung Biologics inks $262M manufacturing deal with European pharma company
September 11, 2026
·
2 min read
·
Nick Paul Taylor
Manufacturing
Sandoz plans ‘vast and vertically integrated’ supply chain to support 100-biosimilar vision
September 9, 2026
·
2 min read
·
Nick Paul Taylor
Insights
Can Benelux turn scientific strength into larger biotech scale?
September 8, 2026
·
4 min read
·
Jennifer C. Smith-Parker
Business
4 CDMOs to consider when outsourcing manufacturing
September 8, 2026
·
5 min read
·
Angela Gabriel
